Albany, NY -- (SBWIRE) -- 06/10/2016 -- Market size and forecast of the cancer testing market in the US and segmentation by technique, including genetic testing and conventional testing. The report discusses the major drivers influencing market growth and the challenges faced by the vendors and the market as a whole. The top vendors evaluated in the report are Abbott Diagnostics, Agilent Technologies, Beckman Coulter, and Roche Diagnostics.

Market outlook of the cancer testing market in the US -

The market in the US is experiencing a lot of transformation in healthcare coverage, which have led to increased accessibility to healthcare, and thereby facilitating early diagnosis, preventive medicine, and personalized medicine. The increase in genetic testing for cancer by end-user segments such as hospitals, diagnostic laboratories, and academics and research institutes are expected to propel the growth of the market.

Technavio predicts the cancer diagnostics market in the US to grow at a steady rate, posting a CAGR of over 9% during the forecast period. Changes in healthcare system is one of the major drivers influencing the market growth. The number of the US citizens covered under healthcare insurance has increased tremendously and today about 19 million citizens in the US have insurance coverage. Also, big companies provide healthcare insurance policies to their employees, which will support the growth of the market.

Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=471568

Competitive landscape and key vendors -

The cancer testing market in the US marks the existence of many small and medium sized vendors offering a diversified product portfolio. Large corporations are acquiring small and medium-sized manufacturers to enhance their product portfolio, which is adding to the competition.

Top vendors in this market are -
- Abbott Diagnostics
- Agilent Technologies
- Beckman Coulter
- Roche Diagnostics

Other prominent vendors included in this report are Affymetrix, Bio-Rad Laboratories, Cardinal Health, Cytyc, Fujirebio Diagnostics, Johnson & Johnson, Pathway Genomics, QIAGEN, Quest Diagnostics, Quidel, and Rosetta Genomics.

Growth drivers, challenges, and upcoming trends: Cancer testing -

Technavios market research analysts highlight the use of mass spectrometer, an extremely sophisticated instrumentation technology, which provide accurate results with infinitesimal amounts of material and does not even require specially purified samples.

This report provides a number of factors contributing to the adoption, limitations, and opportunities of the cancer testing market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.

Browse all "In-Vitro Diagnostics Market" reports at: http://www.researchmoz.us/in-vitro-diagnostics-market-reports-28.html

Key questions answered in this report:
- What will the market size be in 2019 and what will the growth rate be
- What are the key market trends
- What is driving this market
- What are the challenges to market growth
- Who are the key vendors in this market space
- What are the market opportunities and threats faced by the key vendors
- What are the strengths and weaknesses of the key vendors

About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG